Literature DB >> 22142672

Succinylcholine-induced hyperkalemia in a patient with multiple sclerosis.

Michael Levine1, David F M Brown.   

Abstract

BACKGROUND: Succinylcholine administration is associated with hyperkalemia in patients with a variety of medical conditions, including many neuromuscular disorders. Nonetheless, there is a paucity of literature describing hyperkalemia after the administration of succinylcholine to patients with multiple sclerosis. CASE REPORT: This case report describes a 38-year-old woman with multiple sclerosis who developed life-threatening hyperkalemia after the administration of succinylcholine during rapid sequence intubation.
CONCLUSION: This case highlights the potential for iatrogenic hyperkalemia after succinylcholine in patients with neurologic diseases, including multiple sclerosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142672     DOI: 10.1016/j.jemermed.2011.06.062

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  3 in total

1.  Pharmacological interventions for acceleration of the onset time of rocuronium: a meta-analysis.

Authors:  Jing Dong; Lingqi Gao; Wenqing Lu; Zifeng Xu; Jijian Zheng
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

2.  Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis.

Authors:  Chryssoula Staikou; Martina Rekatsina
Journal:  Saudi J Anaesth       Date:  2017 Oct-Dec

Review 3.  Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Authors:  Gregor Lindner; Emmanuel A Burdmann; Catherine M Clase; Brenda R Hemmelgarn; Charles A Herzog; Jolanta Małyszko; Masahiko Nagahama; Roberto Pecoits-Filho; Zubaid Rafique; Patrick Rossignol; Adam J Singer
Journal:  Eur J Emerg Med       Date:  2020-10       Impact factor: 4.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.